{"id":225329,"date":"2026-09-01T10:44:37","date_gmt":"2026-09-01T05:14:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=225329"},"modified":"2026-09-01T10:44:39","modified_gmt":"2026-09-01T05:14:39","slug":"symbiotec-pharmalab-initial-public-offering-listing-today","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/","title":{"rendered":"Symbiotec Pharmalab IPO Lists Flat on NSE, Slips 0.99% on BSE"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Symbiotec Pharmalab lists at Rs 988 on NSE, flat versus issue price. BSE opens at Rs 978.20, down 0.99 percent. Issue price Rs 988. Subscribed 71.26 times overall. Market cap about Rs 6,285.53 Cr.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">The Symbiotec Pharmalab IPO listing today saw the stock debut at Rs 988 on the NSE, unchanged from its Rs 988 issue price, while BSE shares opened at Rs 978.20, a marginal 0.99 percent discount. The mainboard pharma and biotech IPO was subscribed 71.26 times overall. The listing came in well below what grey market indicators had suggested ahead of listing.<\/p>\n<\/div>\n<p><strong>Symbiotec Pharmalab IPO Listing Today:<\/strong> The Symbiotec Pharmalab IPO was subscribed 71.26 times overall by the time bidding closed on 27 August 2026. Within that demand, qualified institutional buyers (QIBs) bid for 172.03 times their reserved portion, non institutional investors (NIIs) put in 73.63 times their quota, and retail investors subscribed 12.96 times the shares set aside for them. Before looking at how the stock performed on debut, here is a recap of the Symbiotec Pharmalab IPO itself, followed by the full Symbiotec Pharmalab IPO listing details.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=symbiotec-pharmalab-listing\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Symbiotec_Pharmalab_IPO\" title=\"Symbiotec Pharmalab IPO\">Symbiotec Pharmalab IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Symbiotec_Pharmalab_Listing\" title=\"Symbiotec Pharmalab Listing\">Symbiotec Pharmalab Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#About_the_Symbiotec_Pharmalab_IPO\" title=\"About the Symbiotec Pharmalab IPO\">About the Symbiotec Pharmalab IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Symbiotec_Pharmalab_Limited_Financials\" title=\"Symbiotec Pharmalab Limited Financials\">Symbiotec Pharmalab Limited Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#What_was_the_Symbiotec_Pharmalab_IPO_listing_price\" title=\"What was the Symbiotec Pharmalab IPO listing price?\">What was the Symbiotec Pharmalab IPO listing price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Was_the_Symbiotec_Pharmalab_IPO_listing_a_premium_or_a_discount\" title=\"Was the Symbiotec Pharmalab IPO listing a premium or a discount?\">Was the Symbiotec Pharmalab IPO listing a premium or a discount?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#How_much_was_the_Symbiotec_Pharmalab_IPO_subscribed\" title=\"How much was the Symbiotec Pharmalab IPO subscribed?\">How much was the Symbiotec Pharmalab IPO subscribed?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#What_is_the_issue_price_of_the_Symbiotec_Pharmalab_IPO\" title=\"What is the issue price of the Symbiotec Pharmalab IPO?\">What is the issue price of the Symbiotec Pharmalab IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#What_is_the_lot_size_of_the_Symbiotec_Pharmalab_IPO\" title=\"What is the lot size of the Symbiotec Pharmalab IPO?\">What is the lot size of the Symbiotec Pharmalab IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Who_is_the_registrar_for_the_Symbiotec_Pharmalab_IPO\" title=\"Who is the registrar for the Symbiotec Pharmalab IPO?\">Who is the registrar for the Symbiotec Pharmalab IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#What_does_Symbiotec_Pharmalab_do\" title=\"What does Symbiotec Pharmalab do?\">What does Symbiotec Pharmalab do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Where_can_I_track_the_Symbiotec_Pharmalab_IPO_listing_performance\" title=\"Where can I track the Symbiotec Pharmalab IPO listing performance?\">Where can I track the Symbiotec Pharmalab IPO listing performance?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-today\/#Did_the_Symbiotec_Pharmalab_IPO_listing_match_grey_market_expectations\" title=\"Did the Symbiotec Pharmalab IPO listing match grey market expectations?\">Did the Symbiotec Pharmalab IPO listing match grey market expectations?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Symbiotec_Pharmalab_IPO\"><\/span><strong>Symbiotec Pharmalab IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Symbiotec Pharmalab Limited raised its capital through a book building issue worth Rs 1,757 crore, made up of a fresh issue of shares worth Rs 150 crore and an offer for sale of Rs 1,607 crore by the promoter and existing investors. The issue listed on both the NSE and the BSE, with a tentative listing date of 1 September 2026. Bidding ran from 24 August 2026 to 27 August 2026, at a face value of Rs 2 per share and a price band of Rs 938 to Rs 988 per share. Anyone tracking the Symbiotec Pharmalab IPO listing today will find the full set of dates and terms in the table below.<\/p>\n<table>\n<thead>\n<tr>\n<th>Particular<\/th>\n<th>Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Allotment Date<\/td>\n<td>28 August 2026<\/td>\n<\/tr>\n<tr>\n<td>IPO Open Date<\/td>\n<td>24 August 2026<\/td>\n<\/tr>\n<tr>\n<td>IPO Close Date<\/td>\n<td>27 August 2026<\/td>\n<\/tr>\n<tr>\n<td>Refund Initiation<\/td>\n<td>31 August 2026<\/td>\n<\/tr>\n<tr>\n<td>Issue Size<\/td>\n<td>Rs 1,757 crore (1,77,86,442 shares)<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>Rs 2 per share<\/td>\n<\/tr>\n<tr>\n<td>Lot Size<\/td>\n<td>15 shares<\/td>\n<\/tr>\n<tr>\n<td>Issue Price<\/td>\n<td>Rs 988 per share<\/td>\n<\/tr>\n<tr>\n<td>Issue Type<\/td>\n<td>Bookbuilding IPO<\/td>\n<\/tr>\n<tr>\n<td>Listing At<\/td>\n<td>NSE, BSE<\/td>\n<\/tr>\n<tr>\n<td>Listing Date<\/td>\n<td>1 September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Live Stock Data on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Symbiotec_Pharmalab_Listing\"><\/span><strong>Symbiotec Pharmalab Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On its listing day, Symbiotec Pharmalab shares opened at Rs 988 apiece on the NSE, exactly in line with the Rs 988 issue price. On the BSE, the stock opened lower at Rs 978.20, a 0.99 percent discount to the issue price. The company&#8217;s market capitalisation stood at about Rs 6,285.53 crore on listing, based on BSE data. The Symbiotec Pharmalab IPO listing fell well short of grey market expectations for a stronger debut, and instead turned out to be a largely muted affair for a mainboard pharma issue of this size. For investors who missed allotment, the Symbiotec Pharmalab IPO listing price now serves as the reference point for deciding whether to buy the stock on the exchanges.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Symbiotec_Pharmalab_IPO\"><\/span><strong>About the Symbiotec Pharmalab IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Symbiotec Pharmalab Limited is an Indore based, research and development driven pharmaceutical and biotechnology company with capabilities across three platforms, organic chemistry, biotechnology, and complex injectables. With more than 30 years of experience, the firm has grown from a lab scale steroidal hormone API manufacturer into an industrial scale, backward integrated manufacturing platform, and it holds approvals from regulators such as the US FDA and the EU-GMP authority. Promoters of the company are Anil Satwani, Kashish Satwani, Sushil Satwani, and Satwani Holdings LLP, while Rosewood Investments and India Business Excellence Fund III were among the selling shareholders in the offer for sale. JM Financial was the lead book running lead manager, alongside Avendus Capital, Motilal Oswal Investment Advisors, and Nomura Financial Advisory and Securities, with MUFG Intime India as registrar. Investors who followed the Symbiotec Pharmalab IPO listing today can use this background to judge whether the muted debut reflects valuation concerns or broader market sentiment around recent mainboard offers. The details above round out the full picture of the Symbiotec Pharmalab IPO listing for readers who applied in the offer.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Symbiotec Pharmalab live share price and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Symbiotec_Pharmalab_Limited_Financials\"><\/span><strong>Symbiotec Pharmalab Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A look at Symbiotec Pharmalab Limited&#8217;s recent financial performance helps put the Symbiotec Pharmalab IPO listing in context for anyone tracking the stock after its debut.<\/p>\n<table>\n<thead>\n<tr>\n<th>Year Ended<\/th>\n<th>31 Mar 2026 (Rs cr.)<\/th>\n<th>31 Mar 2025 (Rs cr.)<\/th>\n<th>31 Mar 2024 (Rs cr.)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Assets<\/td>\n<td>1,780.79<\/td>\n<td>1,579.65<\/td>\n<td>1,294.79<\/td>\n<\/tr>\n<tr>\n<td>Revenue<\/td>\n<td>872.26<\/td>\n<td>755.98<\/td>\n<td>723.33<\/td>\n<\/tr>\n<tr>\n<td>Profit After Tax<\/td>\n<td>109.90<\/td>\n<td>96.79<\/td>\n<td>100.06<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>231.97<\/td>\n<td>206.11<\/td>\n<td>177.04<\/td>\n<\/tr>\n<tr>\n<td>Net Worth<\/td>\n<td>1,158.64<\/td>\n<td>821.15<\/td>\n<td>720.68<\/td>\n<\/tr>\n<tr>\n<td>Reserves and Surplus<\/td>\n<td>1,145.95<\/td>\n<td>810.03<\/td>\n<td>709.54<\/td>\n<\/tr>\n<tr>\n<td>Total Borrowings<\/td>\n<td>387.91<\/td>\n<td>540.92<\/td>\n<td>247.21<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Explanation<\/strong><br \/>\nSymbiotec Pharmalab Limited&#8217;s revenue rose about 15 percent, from Rs 755.98 crore in the year ended 31 March 2025 to Rs 872.26 crore in the year ended 31 March 2026. Profit after tax climbed roughly 14 percent over the same period, moving from Rs 96.79 crore to Rs 109.90 crore, while EBITDA improved from Rs 206.11 crore to Rs 231.97 crore, pointing to steady margin discipline alongside the topline growth. This steady financial trajectory is one of the factors investors are weighing after the Symbiotec Pharmalab IPO listing.<\/p>\n<p>Grey market premium (GMP) is an unofficial, unregulated indicator for the Symbiotec Pharmalab IPO that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data around the Symbiotec Pharmalab IPO listing can go through other relevant sources, though such figures should never be the sole basis for an investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Symbiotec_Pharmalab_IPO_listing_price\"><\/span><strong>What was the Symbiotec Pharmalab IPO listing price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Symbiotec Pharmalab shares listed at Rs 988 on the NSE, flat against the Rs 988 issue price, and opened at Rs 978.20 on the BSE, a 0.99 percent discount.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Was_the_Symbiotec_Pharmalab_IPO_listing_a_premium_or_a_discount\"><\/span><strong>Was the Symbiotec Pharmalab IPO listing a premium or a discount?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The listing was largely flat. NSE shares opened unchanged from the issue price while BSE shares opened at a marginal 0.99 percent discount, well below what grey market indicators had suggested ahead of listing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_was_the_Symbiotec_Pharmalab_IPO_subscribed\"><\/span><strong>How much was the Symbiotec Pharmalab IPO subscribed?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The IPO was subscribed 71.26 times overall, with QIBs at 172.03 times, NIIs at 73.63 times, and retail investors at 12.96 times their respective quotas.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_the_Symbiotec_Pharmalab_IPO\"><\/span><strong>What is the issue price of the Symbiotec Pharmalab IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The issue price was fixed at Rs 988 per share, at the upper end of the Rs 938 to Rs 988 price band.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_lot_size_of_the_Symbiotec_Pharmalab_IPO\"><\/span><strong>What is the lot size of the Symbiotec Pharmalab IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The lot size was 15 shares, translating to a minimum retail investment of about Rs 14,820 at the upper price band.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_for_the_Symbiotec_Pharmalab_IPO\"><\/span><strong>Who is the registrar for the Symbiotec Pharmalab IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> MUFG Intime India Private Limited is the registrar for the Symbiotec Pharmalab IPO.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Symbiotec_Pharmalab_do\"><\/span><strong>What does Symbiotec Pharmalab do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Symbiotec Pharmalab is a pharmaceutical and biotechnology company based in Indore that develops and manufactures active pharmaceutical ingredients, with a focus on corticosteroid and steroidal hormone APIs, across organic chemistry, biotechnology, and complex injectables platforms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_the_Symbiotec_Pharmalab_IPO_listing_performance\"><\/span><strong>Where can I track the Symbiotec Pharmalab IPO listing performance?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track the Symbiotec Pharmalab IPO listing performance and live share price movement on the NSE and BSE, or through the Univest platform.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_the_Symbiotec_Pharmalab_IPO_listing_match_grey_market_expectations\"><\/span><strong>Did the Symbiotec Pharmalab IPO listing match grey market expectations?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. The Symbiotec Pharmalab IPO listing came in well below what grey market indicators had suggested, with the stock instead debuting close to its issue price.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Symbiotec Pharmalab IPO listing today: shares debuted flat at Rs 988 on NSE and slipped 0.99% on BSE, well below GMP-indicated gains. Full listing day report inside.<\/p>\n","protected":false},"author":28,"featured_media":225328,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,3847],"class_list":["post-225329","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-listing-today"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["225328"],"_edit_lock":["1788239681:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["70"],"rank_math_title":["Symbiotec Pharmalab IPO Listing Today: Check Share Price"],"rank_math_description":["Symbiotec Pharmalab IPO listing update: shares debuted flat at Rs 988 on NSE and slipped 0.99 percent on BSE against the Rs 988 issue price. Read the full listing day report."],"rank_math_focus_keyword":["Symbiotec Pharmalab IPO listing"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["40619"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/symbiotec-pharmalab-initial-public-offering-listing-today.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=225329"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225329\/revisions"}],"predecessor-version":[{"id":225346,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/225329\/revisions\/225346"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/225328"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=225329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=225329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=225329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}